rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Shukra Pharmaceuticals Ltd.

524632 SHUKRAPHAR Group (X)

19 Nov,15:29
60.98
-1.70 (-2.71%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Shukra Pharmaceuticals Ltd.

BUYSELL

61,041 62.68 62.00 - 59.55 129.90 - 21.29 267.10
(Rs. Crore)

Financial Results of Shukra Pharmaceuticals Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales74.5758.8320.4911.2011.85
Operating profit19.405.362.891.441.54
Interest0.290.280.290.03-
Gross profit21.936.282.681.771.55
EPS (Rs)16.934.024.790.220.23

See more in Research Center »

News for Pharmaceuticals and health care

Karnataka CM...
Karnataka CM Seeks FM Meeting on NABARD Loan Reduction
Karnataka Chief Minister Siddaramaiah has requested a meeting with Finance Minister Nirmala Sitharaman to discuss a significant reduction in NABARD loans to the state this year.
Nov 20, 2024 13:56
Raheja Developers...
Raheja Developers Challenges Insolvency Over Shilas Project
Raheja Developers has appealed to the NCLAT against the initiation of insolvency proceedings over delays in its Gurugram-based Shilas project, citing force majeure and the project's complexity.
Nov 20, 2024 13:49
ReNew Energy...
ReNew Energy Profit Jumps 31% in Q2 to Rs 440 Crore
ReNew Energy Global Plc reported a 31% rise in net profit to Rs 493.9 crore in the September 2024 quarter, driven by higher income. The company's total income also increased during the period.
Nov 20, 2024 13:20
India-UK FTA...
India-UK FTA Talks Resume: Bridging Gaps for Deal
India and UK will resume FTA talks in 2024, aiming to bridge remaining differences and conclude a deal expeditiously. Both sides seek mutually beneficial outcomes, focusing on trade in goods and...
Nov 20, 2024 13:09
India's GDP...
India's GDP Growth to Slip to 6.5% in Q2 FY25: Icra
Icra forecasts India's GDP growth to slow to 6.5% in Q2 FY25 due to heavy rains and weak corporate performance, but maintains FY25 estimate at 7%.
Nov 20, 2024 13:07

More News »

Top News

Karnataka CM...
Karnataka CM Seeks FM Meeting on NABARD Loan Reduction
Karnataka Chief Minister Siddaramaiah has requested a meeting with Finance Minister Nirmala Sitharaman to discuss a significant reduction in NABARD loans to the state this year.
Nov 20, 2024 13:56
Raheja Developers...
Raheja Developers Challenges Insolvency Over Shilas Project
Raheja Developers has appealed to the NCLAT against the initiation of insolvency proceedings over delays in its Gurugram-based Shilas project, citing force majeure and the project's complexity.
Nov 20, 2024 13:49
COP29: India Urges Rich Nations to Fund Climate Adaptation
India calls on developed countries to increase climate adaptation funding for developing nations, highlighting the growing threat of extreme weather events and the need for a more efficient...
Nov 20, 2024 13:46
ReNew Energy...
ReNew Energy Profit Jumps 31% in Q2 to Rs 440 Crore
ReNew Energy Global Plc reported a 31% rise in net profit to Rs 493.9 crore in the September 2024 quarter, driven by higher income. The company's total income also increased during the period.
Nov 20, 2024 13:20
India-UK FTA...
India-UK FTA Talks Resume: Bridging Gaps for Deal
India and UK will resume FTA talks in 2024, aiming to bridge remaining differences and conclude a deal expeditiously. Both sides seek mutually beneficial outcomes, focusing on trade in goods and...
Nov 20, 2024 13:09

More Top News »

Report Card

PE Ratios
3.60
EPS (Rs.)
16.93
Sales (Rs. Cr)
5.56
Face Value (Rs.)
10
Net Profit Margin (%)
24.85
Last Bonus
3:1
Last Dividend(%)
10
Return on Average Equity
32.16

Compare 'Shukra Pharmaceuticals Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,747.20
  • Compare
  • Divi's Laboratories Ltd.
  • 5,762.85
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,105.65
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 1,193.35
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,743.25
  • Compare
  • Max Healthcare Institute Ltd.
  • 1,000.85
  • Compare
  • Zydus Lifesciences Ltd.
  • 944.95
  • Compare
  • Aurobindo Pharma Ltd.
  • 1,235.15
  • Compare

Most Active

  • Change (Rs.)
  •  

Shukra Pharmaceuticals Ltd. performance snapshot

If you had invested Rs.  in Shukra Pharmaceuticals Ltd.,     ago

You would have  Rs. 939.17 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Shukra Pharmaceuticals Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Shukra Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close